Skip to main content

clinical trials Archives

VUMC partners with Yale and Morehouse Schools of Medicine, industry organizations to increase diversity in clinical trials

Jul. 21, 2022—Vanderbilt is partnering with Yale School of Medicine, Morehouse School of Medicine and the Research Centers in Minority Institutions Coordinating Center at the Morehouse School of Medicine in an initiative aimed at increasing diversity in clinical trials and addressing systemic barriers to participation by communities of color.

Read more


Study finds similar success rates with two devices for breathing tube placement

Dec. 15, 2021—Two devices for placing a breathing tube during critical illness had similar success rates for intubation on the first attempt, according to a study published Dec. 8 in JAMA.

Read more


Reid selected for clinical trial development program

Dec. 2, 2021—Vanderbilt's Sonya Reid, MD, MPH, has been selected to participate in the first cohort of the Bristol Myers Squibb Foundation Clinical Trial Diversity Career Development Program.

Read more


Shifts in neuroendocrine cancer clinical trial design

Nov. 2, 2021—Clinical trials that focus on specific types of neuroendocrine neoplasms — heterogeneous tumors that can occur anywhere in the body — will be more likely to enhance drug development for these tumors, Vanderbilt physicians assert.

Read more


Reid receives NRG Oncology early-stage investigator award

Oct. 28, 2021—Vanderbilt's Sonya Reid, MD, MPH, is a recipient of an NRG Oncology Underserved Minority Scholars Award.

Read more


STAR Clinical Research Network to receive major grant renewal

Oct. 14, 2021—Vanderbilt's STAR Clinical Research Network has been approved for an additional $8.9 million in funding from the Patient-Centered Outcomes Research Institute (PCORI) to support its efforts to improve health care throughout the Southeast and across the United States.

Read more


Photoimmunotherapy offered in clinical trial for recurrent head and neck cancer

Oct. 14, 2021—Vanderbilt-Ingram Cancer Center is recruiting patients for a clinical trial using photoimmunotherapy for recurrent head and neck cancer.

Read more


Clinical trial tests ATR inhibitor in difficult-to-treat cancers

Sep. 23, 2021—  by Tom Wilemon A clinical trial has been launched to test a new targeted therapy in patients with advanced and difficult-to-treat cancers. Satya Das, MD, MSCI, assistant professor of Medicine at Vanderbilt-Ingram Cancer Center (VICC), is the national principal investigator for the trial (NCT04514497) that is now enrolling people with metastatic small cell lung...

Read more


Eng named co-chair of NCI clinical trials steering committee

Sep. 23, 2021—Vanderbilt's Cathy Eng, MD, has been elected co-chair of the National Cancer Institute (NCI) Gastrointestinal Cancer Steering Committee.

Read more


‘DNA’ podcast Season 2 explores COVID, science and trust in communities

Aug. 23, 2021—Listen to Episode 1, Blueprint for a Pandemic-Ready Society, and subscribe on your favorite platform. The first episode of the second season of Vanderbilt University Medical Center’s original podcast series, Vanderbilt Health DNA: Discoveries in Action, tackles bold questions and issues pushed to the surface by COVID-19. This season, the award-winning 10-episode series delves into...

Read more


VUMC, NIH launch clinical trial to test novel therapies to protect host tissue against COVID-19

Jul. 26, 2021—Vanderbilt University Medical Center researchers, supported by the National Institutes of Health (NIH), are leading a nationwide clinical trial to explore the safety and effectiveness of a group of novel drugs designed to protect patients hospitalized with COVID-19 at high risk of poor outcomes.

Read more


Ciombor chosen for NCI clinical investigator team leadership award

Jul. 15, 2021—Kristen Ciombor, MD, MSCI, is one of 10 physicians nationwide selected by the National Cancer Institute (NCI) for the 2021 Cancer Clinical Investigator Team Leadership Award.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more